EQUITY RESEARCH MEMO
Opis Research
Generated 5/10/2026
Executive Summary
Conviction (model self-assessment)50/100
Opis Research is a data-driven, quality-focused clinical Contract Research Organization (CRO) headquartered in Milan, Italy. Founded in 2015, the company specializes in neuroscience and oncology, offering services for both interventional and non-interventional multi-country trials. With a team experienced in new-generation drugs, advanced therapeutic procedures, and biologic treatments, Opis collaborates with international sponsors to bring innovative therapies to market. Despite operating at a pre-clinical stage, the company has established a strong reputation for robust data management and regulatory compliance, positioning itself as a reliable partner in complex clinical research environments.
Upcoming Catalysts (preview)
- Q3 2026Major contract win with a top pharmaceutical company60% success
- Q4 2026Expansion of service offerings into new therapeutic areas50% success
- TBDStrategic partnership with a clinical trial technology provider40% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)